These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20832214)

  • 1. [Two cases of Fanconi's syndrome induced by tenofovir in the Ivory Coast].
    Ondounda M; Tanon A; Ehui E; Ouattara I; Kassi A; Aba YT; Aoussi EF; Kakou AR; Eholié SP; Bissagnene E; Kadio A
    Med Mal Infect; 2011 Feb; 41(2):105-7. PubMed ID: 20832214
    [No Abstract]   [Full Text] [Related]  

  • 2. [Atazanavir-induced nephrolithiasis].
    Valencia ME; Moreno V
    Enferm Infecc Microbiol Clin; 2009 Feb; 27(2):134-5. PubMed ID: 19246127
    [No Abstract]   [Full Text] [Related]  

  • 3. [Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV].
    Bayonne Kombo ES; Gathse A
    Med Mal Infect; 2013 Mar; 43(3):134-5. PubMed ID: 23434355
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of bone gammagraphy in the diagnosis of secondary osteomalacia in a patient treated with tenofovir].
    Torres Isidro MV; García Benayas T; del Val Gómez Martínez M; González Gallardo F; Gambí Pisonero N; Castilla Miguel S; González-Lahoz J; Gallego Sanz D
    Rev Esp Med Nucl; 2006; 25(2):103-6. PubMed ID: 16759616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased antiretroviral potency by the addition of enfuvirtide to a four-drug regimen in antiretroviral-naive, HIV-infected patients.
    Moltó J; Ruiz L; Valle M; Martinez-Picado J; Bonjoch A; Bravo I; Negredo E; Heilek-Sneider GM; Clotet B
    Antivir Ther; 2006; 11(1):47-51. PubMed ID: 16518959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized, double-blind, placebo-matched, multicenter trial of abacavir/lamivudine or tenofovir/emtricitabine with lopinavir/ritonavir for initial HIV treatment.
    Smith KY; Patel P; Fine D; Bellos N; Sloan L; Lackey P; Kumar PN; Sutherland-Phillips DH; Vavro C; Yau L; Wannamaker P; Shaefer MS;
    AIDS; 2009 Jul; 23(12):1547-56. PubMed ID: 19542866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open-label pilot study to determine the efficacy of lopinavir/ritonavir and tenofovir DF in the treatment of HIV-infected patients experiencing first virologic failure on a non-nucleoside-based regimen.
    Pierone G; Mieras J; Bulgin-Coleman D; Kantor C; Shearer J; Fontaine L; Fath M
    AIDS Patient Care STDS; 2008 Apr; 22(4):263-6. PubMed ID: 18422459
    [No Abstract]   [Full Text] [Related]  

  • 8. Fanconi syndrome-like tubular acidosis associated with a tenofovir-containing antiretroviral regimen in a human immunodeficiency virus-1-infected Asian woman.
    Kiyasu Y; Koganemaru H; Hitomi S
    J Infect Chemother; 2012 Apr; 18(2):255-7. PubMed ID: 21918819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determining the relative efficacy of highly active antiretroviral therapy.
    Louie M; Hogan C; Di Mascio M; Hurley A; Simon V; Rooney J; Ruiz N; Brun S; Sun E; Perelson AS; Ho DD; Markowitz M
    J Infect Dis; 2003 Mar; 187(6):896-900. PubMed ID: 12660935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney damage reported in some tenofovir users.
    TreatmentUpdate; 2003; 15(2):6-7. PubMed ID: 12693362
    [No Abstract]   [Full Text] [Related]  

  • 11. Raltegravir as effective as efavirenz in 144-week data.
    AIDS Patient Care STDS; 2009 Aug; 23(8):679-80. PubMed ID: 19694035
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction therapy with enfuvirtide-based highly active antiretroviral therapy in a patient with acute HIV-1 infection.
    Polk C; Chan-Tack KM; Kopack AM; Amoroso A
    AIDS Patient Care STDS; 2007 Feb; 21(2):75-7. PubMed ID: 17328655
    [No Abstract]   [Full Text] [Related]  

  • 13. [HIV infected women with intense bone and muscular pain and general weakness].
    Pérez-Rivera AÁ; Sáez P; León E; Lozano de León-Naranjo F
    Enferm Infecc Microbiol Clin; 2011 Apr; 29(4):308-10. PubMed ID: 21334782
    [No Abstract]   [Full Text] [Related]  

  • 14. Nephrotoxicity in a child with perinatal HIV on tenofovir, didanosine and lopinavir/ritonavir.
    Hussain S; Khayat A; Tolaymat A; Rathore MH
    Pediatr Nephrol; 2006 Jul; 21(7):1034-6. PubMed ID: 16773419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection.
    Walmsley S; Bernstein B; King M; Arribas J; Beall G; Ruane P; Johnson M; Johnson D; Lalonde R; Japour A; Brun S; Sun E;
    N Engl J Med; 2002 Jun; 346(26):2039-46. PubMed ID: 12087139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients.
    Delfraissy JF; Flandre P; Delaugerre C; Ghosn J; Horban A; Girard PM; Norton M; Rouzioux C; Taburet AM; Cohen-Codar I; Van PN; Chauvin JP
    AIDS; 2008 Jan; 22(3):385-93. PubMed ID: 18195565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenofovir-related Fanconi's syndrome and osteomalacia in a teenager with HIV.
    Lucey JM; Hsu P; Ziegler JB
    BMJ Case Rep; 2013 Jul; 2013():. PubMed ID: 23843401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenofovir-related Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome: the role of lopinavir-ritonavir-didanosine.
    Rollot F; Nazal EM; Chauvelot-Moachon L; Kélaïdi C; Daniel N; Saba M; Abad S; Blanche P
    Clin Infect Dis; 2003 Dec; 37(12):e174-6. PubMed ID: 14689363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of tenofovir/emtricitabine or abacavir/lamivudine in combination with efavirenz in treatment naïve HIV patients: a 5 year retrospective observational cohort study. (the TOKEN Study).
    Pammi M; Arumainayagam J; Kumari B; Ahmed-Jushuf I; Carlin EM; Chandramani S; Riddell L; Ghanem M; Das S
    Int J Clin Pract; 2013 Sep; 67(9):922-3. PubMed ID: 23952469
    [No Abstract]   [Full Text] [Related]  

  • 20. New once-daily HIV combination better tolerated.
    Expert Rev Anti Infect Ther; 2004 Dec; 2(6):826. PubMed ID: 15566325
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.